Author

M. Gleave

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Approach:experimental assay· 3 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Assay:ChIP-seq· 1

Frequent Co-Authors

C. Collins· 2 shared L. Fazli· 2 shared A. CHAUCHEREAU· 1 shared A. Cherkasov· 1 shared A. Cingoz· 1 shared A. Foye· 1 shared A. LE PAPE· 1 shared A. Molinolo· 1 shared

Activity by Year

2016-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 13 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

C. Collins

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

HOXB13 alters chromatin accessibility in prostate cancer through interactions with the SWI/SNF complex

S. Lingadahalli, B. E. Fazlioglu, U. B. Altintas, A. Cingoz, E. Tekoglu, I. P. L. Yu, H. Andomat, I. Kulac, T. Morova, K. Xiao, U. M. Dikbas, M. Gleave, L. Fazli, P. Cejas, H. Long, , N. A. Lack

This study shows HOXB13 promotes prostate cancer proliferation by altering chromatin accessibility through interactions with the SWI/SNF complex, particularly in AR-negative castration-resistant prostate cancer.

bioRxiv · Sep 4, 2023 · PreprintCancer Biology

RNF185 control of COL3A1 expression limits prostate cancer migration and metastatic potential.

B. Van Espen, H. Z. Oo, C. Collins, L. Fazil, A. Molinolo, R. Murad, M. Gleave, Z. A. Ronai

This study shows RNF185 limits prostate cancer migration and metastasis by controlling COL3A1 expression.

bioRxiv · Jun 29, 2023Cancer Biology

Autoantibody landscape of advanced prostate cancer

W. S. Chen, W. A. Haynes, R. Waitz, K. Kamath, A. Vega-Crespo, R. Shrestha, M. Zhang, A. Foye, I. Baselga Carretero, I. Garcilazo Perez, M. Zhang, S. G. Zhao, M. Sjostrom, D. A. Quigley, J. Chou, , F. Y. Feng

This study characterizes the autoantibody landscape in metastatic castration-resistant prostate cancer using serum epitope repertoire analysis and identifies novel tumor-specific epitopes.

bioRxiv · May 2, 2020 · PreprintCancer Biology

Regulation of eIF4F complex by the peptidyl prolyl isomerase FKBP7 in taxane-resistant prostate cancer

M. F. GARRIDO, N. J. MARTIN, C. GAUDIN, F. Commo, N. AL NAKOUZI, L. FAZLI, E. DEL NERY, J. Camonis, F. Perez, S. LERONDEL, A. LE PAPE, H. ABOU-HAMDAN, M. Gleave, Y. Loriot, L. DESAUBRY, , A. CHAUCHEREAU

This study identifies FKBP7 as a molecular chaperone that regulates the eIF4F complex in taxane-resistant prostate cancer, and shows that inhibiting eIF4A can overcome resistance.

bioRxiv · Dec 22, 2016Cancer Biology